Monopar Therapeutics Inc. · NASDAQ:MNPR
Janus Henderson Group PLC reported a 18.60% stake in Monopar Therapeutics Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 18.60% stake in Monopar Therapeutics Inc., 1,134,406 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 18.60%
- Shares
- 1,134,406
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 18.60% | 1,134,406 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 16.50% | 1,006,928 |
Source
Related
- Monopar Therapeutics Inc.
- Janus Henderson Group PLC
- Monopar Therapeutics Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Nov 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Jan 8, 2025
- Form 4 · Robinson Chandler · Oct 20, 2026
- Form 4 · Starr Christopher M · Oct 5, 2026
- Form 4 · Cittadine Andrew · Oct 2, 2026
- Form 4 · Vu Quan Anh · Oct 2, 2026
- Form 4 · Robinson Chandler · Oct 2, 2026